/Companies

Memento Medicines

Boston, US · Founded 2025 · Delaware corporation · 5 known investors

Find your way into Memento Medicines

Sign up to see every warm intro you have to Memento Medicines

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Memento Medicines team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Privately-held biotech company developing biologic therapies for retinal diseases

Founders & leadership

WD
William Daley BonificioNamed on SEC filing
SB
Stephen Basil ThomasNamed on SEC filing
NM
Naveen Manu DaryaniNamed on SEC filing

Board

ZSZach Scheiner
Zach ScheinerBoard directorPartner at RA Capital
MK
Megan KrenchBoard director
DHDmitrij Hristodorov
Dmitrij HristodorovBoard MemberGeneral Partner at Forbion
VK
Vishal KapoorBoard director

Investors · 5

Reported raises · per SEC filings

Form D private placements

$38M disclosed across 1 round · 2026

▶$38MraisedJun 2026 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Zach ScheinerDirector
  • William Daley BonificioExecutive Officer, Promoter
  • Megan KrenchDirector
  • Stephen Basil ThomasExecutive Officer, Promoter
  • Dmitrij HristodorovDirector
  • Naveen Manu DaryaniExecutive Officer, Director, Promoter
  • Vishal KapoorDirector
Offering amount
$93M
Amount sold
$38M
First sale
Jun 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Memento Medicines do?
Privately-held biotech company developing biologic therapies for retinal diseases
Who are Memento Medicines's investors?
Memento Medicines's investors include Avego BioScience Capital, RA Capital, Sanofi Ventures, Forbion, Samsara BioCapital.
How much funding has Memento Medicines raised?
Memento Medicines has disclosed $38M raised across 1 round.
Where is Memento Medicines headquartered?
Memento Medicines is headquartered in Boston, US.